Hidetoshi Shimizu

Title: Hidetoshi Shimizu: Innovator in Pharmaceutical Composition

Introduction

Hidetoshi Shimizu is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of oxidative stress diseases. With a total of three patents to his name, Shimizu's work is recognized for its innovative approaches to drug administration.

Latest Patents

One of Hidetoshi Shimizu's latest patents is a pharmaceutical composition for the oral administration of edaravone. This method involves administering the composition to a subject in need, with specific time intervals after meal consumption. The intervals are designed to optimize the effectiveness of the treatment, being 8 hours or longer after a high-fat meal, 4 hours or longer after a standard meal, or 2 hours or longer after a light meal. This innovative approach aims to enhance the therapeutic outcomes for patients suffering from oxidative stress diseases.

Career Highlights

Hidetoshi Shimizu is currently associated with Mitsubishi Tanabe Pharma Corporation, where he continues to advance his research and development efforts. His work has been instrumental in creating effective pharmaceutical solutions that address critical health issues.

Collaborations

Shimizu collaborates with esteemed colleagues such as Yoshinobu Nakamaru and Yukiko Nishimura. Their combined expertise contributes to the innovative environment at Mitsubishi Tanabe Pharma Corporation.

Conclusion

Hidetoshi Shimizu's contributions to pharmaceutical innovation, particularly in the administration of edaravone, highlight his role as a leading inventor in the field. His work not only advances medical science but also offers hope for patients dealing with oxidative stress diseases.